PAULA NARANJO: Open Payments
NPI 1154184828 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$175 in 8 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $424 · 2025 $175
Food & beverage: $175
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 2 | $42 |
| Grifols Shared Services North America, Inc. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Baxter Healthcare | 1 | $24 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| JAZZ PHARMACEUTICALS INC. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Prolastin-C Liquid, Thrombate III, DUPIXENT, Hillrom - Vest System Model 105 Home Care, PURIFIED CORTROPHIN GEL, XYWAV, TEZSPIRE.
Industry payments across TX — which companies pay providers there.
